Report
Cheplapharm Arzneimittel : We have trust in the business model
Chepla is suffering from persisting supply chain headwinds. This is applicable to the pharma industry as a whole, but is more elevated in their case, though. Management has initiated measures to mitigate the impacts. But FY 24 is rather a transformation year. We believe it is a temporary headwind, which stipulates our Stable Credit Opinion. - They key consideration for us is that Chepla, despite the structural organic decline of the portfolio (as a result of the off-patent product ...
Provider
Oddo BHF
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Markus Schmitt
Other Reports from Oddo BHF
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.